Table 1.

All-Cause Mortality Rates of 16,509 Participants of NHANES III Aged ≥17 Years, by Hepatitis C Virus (HCV) Antibody and RNA Status

	HCV antibody negative		HCV antibody positive (RNA positive and negative)		HCV antibody positive and HCV RNA positive (chronic infection)
	n	Mortality rate (95% CI) deaths per 1000 person-years	n	Mortality rate (95% CI) deaths per 1000 person-years	n	Mortality rate (95% CI) deaths per 1000 person-years
All participants	16,157	11.1 (10.1–12.2)	352	14.8 (9.9–22.1)	279	16.5 (10.5–26.0)
Men
Total	7535	11.6 (10.5–12.7)	212	16.2 (9.9–26.3)	174	17.1 (10.0–29.4)
17–29 yr	1971	2.3 (1.5–3.4)	39	1.9 (0.6–6.2)	33	2.3 (0.7–8.1)
30–44 yr	1934	2.3 (1.6–3.1)	104	13.1 (6.7–25.6)	92	15.7 (7.2–29.9)
45–59 yr	1255	11.2 (9.1–13.7)	40	24.3 (10.4–56.9)	31	36.2 (16.2–80.9)
≥60 yr	2375	54.2 (49.3–59.6)	29	157.0 (98.0–251.7)	18	200.6 (109.1–390.4)
Women
Total	8622	10.6 (9.6–11.8)	140	12.5 (6.9–22.7)	105	15.3 (7.5–31.1)
17–29 yr	2267	1.2 (0.8–2.0)	19	3.2 (0.7–15.5)	13	4.9 (1.0–25.3)
30–44 yr	2441	1.8 (1.2–2.6)	69	2.7 (1.2–6.4)	53	3.2 (1.4–7.3)
45–59 yr	1418	8.5 (6.8–10.6)	28	20.8 (6.9–62.9)	21	22.4 (6.5–77.2)
≥60 yr	2496	43.4 (39.2–47.9)	24	64.5 (34.8–119.7)	18	83.4 (50.0–139.0)

NOTE. CI, confidence interval.